Navigation Links
HealthLink Europe's U.S. Operation Supports First FDA IDE Trial
Date:11/11/2013

RALEIGH, N.C. and 'S-HERTOGENBOSCH, Netherlands, Nov. 11, 2013 /PRNewswire/ -- HealthLink Europe, an ISO 13485:2012 certified company specializing in providing front and back office support, VAT deferment, fulfillment and logistics services to medical device companies since 1994, is now supporting a European-based client's FDA IDE Trial in the United States for a Class III device in the interventional cardiology space.

HealthLink Europe has had a Business Development and Client Relations office based in Raleigh, North Carolina since 2004, but they have now expanded their North American capabilities to include logistical support. HealthLink's expansion of operational services to the U.S. offers its current clients the advantage of working with the same platform for their sites in the U.S. as they do for their European operations.

HealthLink plans to grow its North American warehousing and logistics services with the expansion of its U.S. team based in Raleigh, North Carolina. Sebastiaan "Bas" de Kok, Operations Manager at HealthLink Europe, will join the U.S.A. team this year, bringing with him the knowledge and experience necessary to further develop HealthLink's North American endeavor.

"It is our plan to have a North American operation that offers similar services to our current European facility in the Netherlands," explains Rick Hughes, president of HealthLink Europe. "We're very excited about our expansion and we're looking forward to supporting our clients as they expand into other markets."

ABOUT HEALTHLINK EUROPE:
HealthLink Europe is 100% medical, ISO 13485 certified, specializing in class II and III devices and their associated regulatory requirements.

Acting as an extension of its customers' business, HealthLink provides Customer Care Services, Financial Services, Warehousing and Logistics, Fulfillment and Value Added Services, IT Support, Authorized Representative services, and more.

For more information, visit www.healthlinkeurope.com, or call Toll Free:(800) 781-8926.

For media inquiries, please contact:
Savanna Bohlman Fann
Communications Manager, HealthLink Europe
(800) 781-8926


'/>"/>
SOURCE HealthLink Europe
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
2. PharmAthene Reports Third Quarter 2013 Financial And Operational Results
3. Intersurgical, ERDRICH Umformtechnik und Bridgestone gehen Kooperation mit dem Changzhou National Hi-Tech District ein
4. Celtaxsys Restructures, Enhances Operational Focus
5. Neue Studie kommt zu dem Schluss, dass manche Patienten mit Refluxkrankheit von Stretta eher profitieren als von chronischer Behandlung mit Protonenpumpenhemmern oder Antireflux-Operation
6. GenVec Board Restructures Operations and Withdraws Plan of Dissolution
7. X-Change Corp. Delighted with DOJs Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees Green Light for Companys Patient-Driven Medical Cannabis Operations Under State Laws
8. PA Governor Corbett: Americure Rx Establishes Operations in Lehigh Valley; Creates 51 Jobs
9. PendoTECH Launches New In-line Single Use Conductivity Sensors for Critical Bioprocess Operations
10. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
11. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... The Georgia State University College of Law new ... Urban Design Commission. , The annual award recognizes projects, programs, individuals and organizations that ... preservation of its physical heritage and the balance between the old and the new. ...
(Date:5/25/2016)... ... 2016 , ... A new update to Xsens popular data analysis ... a common Wi-Fi network and a mobile device. When paired with Xsens MVN or ... and use a mobile device to control the recording. , “The update adds ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... One Florida-based ... potential patients, according to an article published May 13th on Vanity Fair. ... comfortable with having snippets of their procedures broadcast to more than 800,000 Snapchat fans. ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Bank of America Charitable Foundation has awarded ... provide veterans a pathway to employment and successful careers in healthcare. On Wednesday, May ... Hallack, President and CEO of Medisend, parent organization and home of the General Myers ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies ... of injured workers across 15 states. The outcomes examined in these studies include ... medical care, and satisfaction with medical care. , “The goal of the studies ...
Breaking Medicine News(10 mins):